QL Biotech's Advanced Tuberculosis Rapid Test Kit for Efficient Diagnosis

Short Description:

The Leishmania IgG/IgM Rapid Test is a lateral flow immunoassay for the qualitative detection of antibodies including IgG and IgM to the subspecies of the Leishmania donovani (L. donovani), the Visceral leishmaniasis causative protozoans in human serum or plasma. This test is intended to be used as a screening test and as an aid in the diagnosis of the disease of Visceral leishmaniasis. Any reactive specimen with the Leishmania IgG/IgM Rapid Test must be confirmed with alternative testing method(s).


Product Detail

Product Tags

At QL Biotech, we are dedicated to driving medical advancements to improve the quality of healthcare. Our Tuberculosis Rapid Test Kit, an innovative product, promises efficient and reliable performance. The product is based on a qualitative membrane strip immunoassay, making it capable of instantaneously detecting antibodies in Whole Blood/Serum/Plasma. Our Tuberculosis Rapid Test Kit is designed to provide rapid results, enabling quick actions. It utilises a cutting-edge detection technique to isolate the Tuberculosis antibodies, both IgG and IgM. The accuracy of our kit has escalated it to a top position in the medical industry.

PRINCIPLE

HSV‐1 IgG/IgM (HSV-2 IgG/IgM)Test is a qualitative membrane strip based immunoassay for the detection of HSV‐1 antibodies (IgG and IgM) in Whole Blood/Serum/Plasma. The test device consists of: 1) a burgundy colored conjugate pad containing HSV recombinant envelope antigens conjugated with Colloid gold (HSV conjugates) and rabbit IgG‐gold conjugates,2) a nitrocellulose membrane strip containing two test bands (T1 and T2 bands) and a control band (C band). The T1 band is pre‐coated with the antibody for the detection of IgM anti‐HSV, T2 band is coated with antibody for the detection of IgG anti‐HSV, and the C band is pre‐coated with goat anti rabbit IgG.

When an adequate volume of test specimen is dispensed into the sample well of the test cassette, the specimen migrates by capillary action across the cassette. IgG anti‐HSV, if present in the specimen, will bind to the HSV conjugates. The immunocomplex is then captured by the reagent pre‐coated on the T2 band, forming a burgundy colored T2 band, indicating a HSV IgG positive test result and suggesting a recent or repeat infection. IgM anti‐HSV if present in the specimen will bind to the HSV conjugates. The immunocomplex is then captured by the reagent coated on the T1 band, forming a burgundy colored T1 band, indicating a HSV IgM positive test result and suggesting a fresh infection. Absence of any T bands (T1 and T2) suggests a negative result. The test contains an internal control (C band) which should exhibit a burgundy colored band of the immunocomplex of goat anti rabbit IgG/rabbit IgG‐gold conjugate regardless of the color development on any of the T bands. Otherwise, the test result is invalid and the specimen must be retested with another device.


Product Detail

Brand: QL

Specimens: : Whole Blood/Serum/Plasma

Reading time:15 minutes.

Pack:25 T

STORAGE: 2‐30°C

KIT COMPONENTS

  • Test devices
  • Droppers
  • Buffer
  • Package insert

 

PROCEDURE

    • 1. Bring the pouch to room temperature before opening it. Remove the test device from the sealed pouch and use it as soon as possible. 
      2. Place the test device on a clean and level surface. For Whole Blood, Serum or Plasma specimens: Hold the dropper vertically and transfer 2 drops of specimen (or approximately 50 µL) to the specimen well (S) of the test device, then add 1 drop of buffer for serum or plasma and 2 drops of buffer for whole blood. Start the timer. 
      For Fingerstick Whole Blood specimens: 
      To use a capillary tube: Fill the capillary tube and transfer approximately 50 µL (or 2 drops) of fingerstick whole blood specimen to the specimen well (S) of the test device, then add 2 
      drops of buffer and start the timer. 
      3. Wait for the colored line(s) to appear. Read results at 15 minutes. Do not interpret results after 30 minutes. 

    INTERPRETATION OF RESULTS



    IgMPositive:* The colored line in the control line region (C) appears and a colored line appears in test line region 2 (T2). The result is positive for Leishmania specific‐IgM antibodies.

    IgGPositive:* The colored line in the control line region (C) appears and a colored line appears in test line region 1 (T1). The result is positive for Leishmania specific‐IgG.

    IgG and IgM Positive:* The colored line in the control line region (C) appears and two colored lines should appear in test line regions 1 and 2 (T1 and T2). The color intensities of the lines do not have to match. The result is positive for IgG & IgM antibodies.

    *NOTE: The intensity of the color in the test line region(s) (T1 and/or T2) will vary depending on the concentration of Leishmania antibodies in the specimen. Therefore, any shade of color in the test line region(s) (T1 and/or T2) should be considered positive.

    The colored line in the control line region (C) appears. No line appears in test line regions 1 or 2 (T1 or T2).

    Controlline(C) falls toappear.Insufficient buffer volume or incorrect procedural techniques are the most likely reasons for control line failure.

    Review the procedure and repeat the procedure with a new test device. If the problem persists, discontinue using the test kit immediately and contact your local distributor.




    Every Tuberculosis Rapid Test Kit from QL Biotech ensures not just speed, but also precision, thereby minimizing the possibility of false positives and negatives. We have moved away from the conventional, time-consuming methods, and embraced new-age solutions that yield swift results and do not require highly skilled personnel or elaborate equipment. In conclusion, QL Biotech's Tuberculosis Rapid Test Kit is an essential tool for clinics, laboratories, and healthcare facilities that eagerly look for quick, reliable, and accurate diagnostic solutions. It's more than just a kit - it's a promise of speedy diagnosis, effective cure, and an overall improved healthcare environment.

  • Previous:
  • Next: